Anzeige
Mehr »
Login
Donnerstag, 23.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Mit dieser Aktie könntest Du von der Cannabis-Legalisierungswelle profitieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P5NL | ISIN: US37148K1007 | Ticker-Symbol:
NASDAQ
22.05.24
22:00 Uhr
3,370 US-Dollar
-0,020
-0,59 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
GENERATION BIO CO Chart 1 Jahr
5-Tage-Chart
GENERATION BIO CO 5-Tage-Chart

Aktuelle News zur GENERATION BIO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14.05.Generation Bio Co reports results for the quarter ended in March - Earnings Summary1
13.05.Generation Bio Co. - 10-Q, Quarterly Report1
13.05.Generation Bio Co.: Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results20- Oral presentation at ASGCT described selective, high levels of therapeutic transgene delivery to T cells in vivo by cell-targeted lipid nanoparticle (ctLNP) - ASGCT poster presentations described...
► Artikel lesen
13.05.Generation Bio Co. - 8-K, Current Report1
22.04.Generation Bio Co.: Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting49CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today...
► Artikel lesen
07.03.Generation Bio GAAP EPS of -$0.532
07.03.Generation Bio Co reports results for the quarter ended in December - Earnings Summary3
06.03.Generation Bio Co. - S-8, Securities to be offered to employees in employee benefit plans2
06.03.Generation Bio Co. - 10-K, Annual Report1
06.03.Generation Bio Co. - 8-K, Current Report1
06.03.Generation Bio Co.: Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results798- Company is leveraging proprietary cell-targeted lipid nanoparticle delivery to develop wholly-owned in vivo program for sickle cell disease and beta-thalassemia - Development of breakthrough immune-quiet...
► Artikel lesen
27.02.Generation Bio Co.: Generation Bio to Present at the 2024 TD Cowen Health Care Conference2
02.02.Generation Bio Co. - 8-K, Current Report2
08.01.Generation Bio Co. - 8-K, Current Report1
29.11.23Generation Bio to cut 40% of staff in business reorganization5
29.11.23Generation Bio eliminates 40% of staff, including 2 C-suite execs, in pivot to ex-liver targets2
29.11.23Generation Bio Co. - 8-K, Current Report1
29.11.23Generation Bio Co.: Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms414Company to invest in highly selective cell-targeted lipid nanoparticle (ctLNP) delivery platform to develop wholly-owned programs for extrahepatic cell typesDevelopment of immune-quiet DNA (iqDNA)...
► Artikel lesen
09.11.23Generation Bio Co.: Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results297- Immune-quiet DNA evades innate immune sensors in both mice and non-human primates addressing a central challenge for non-viral DNA therapeutics - Proprietary cell-targeted LNP delivery system...
► Artikel lesen
02.08.23Generation Bio Co.: Generation Bio Reports Second Quarter 2023 Financial Results425CAMBRIDGE, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1